APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma Regulatory Intelligence Service

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pharma Regulatory Intelligence Service Industry Research Report 2026

1 January 2026139 pages

Choose your research edition.

Industry ResearchPharma Regulatory Intelligence Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma Regulatory Intelligence Service Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Pharma Regulatory Intelligence Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma Regulatory Intelligence Service Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma Regulatory Intelligence Service Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Pharma Regulatory Intelligence Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Pharma Regulatory Intelligence Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharma Regulatory Intelligence Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharma Regulatory Intelligence Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharma Regulatory Intelligence Service include ProPharma, IQVIA, Clarivate, InfoDesk, Vigilare, DDReg Pharma, Redica Systems, ArisGlobal and Freyr, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Pharma Regulatory Intelligence Service market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharma Regulatory Intelligence Service.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pharma Regulatory Intelligence Service Market by Company

ProPharma

IQVIA

Clarivate

InfoDesk

Vigilare

DDReg Pharma

Redica Systems

ArisGlobal

Freyr

PPD

Ergomed

SCR Consulting

CUBE

Vistaar

ProductLife Group

Deontea

PrimeVigilance

Deloitte

Cullen International

Arriello

Veristat

Celegence

Zenovel

STUP

iVigee

QbD Group

Biomapas

Pharma Regulatory Intelligence Service Segment by Type

Database Driven Services

Software Based Services

Artificial Intelligence Services

Pharma Regulatory Intelligence Service Segment by Application

Pharmaceuticals

Medical Devices

Other

Pharma Regulatory Intelligence Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Regulatory Intelligence Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma Regulatory Intelligence Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Regulatory Intelligence Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Pharma Regulatory Intelligence Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pharma Regulatory Intelligence Service Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Pharma Regulatory Intelligence Service Revenue Market Share by Type (2021-2026) Table 7. Global Pharma Regulatory Intelligence Service Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Pharma Regulatory Intelligence Service Revenue Market Share by Type (2027-2032) Table 9. Global Pharma Regulatory Intelligence Service Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Pharma Regulatory Intelligence Service Revenue Market Share by Application (2021-2026) Table 11. Global Pharma Regulatory Intelligence Service Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Pharma Regulatory Intelligence Service Revenue Market Share by Application (2027-2032) Table 13. Global Pharma Regulatory Intelligence Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pharma Regulatory Intelligence Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pharma Regulatory Intelligence Service Market Share by Region (2021-2026) Table 16. Global Pharma Regulatory Intelligence Service Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pharma Regulatory Intelligence Service Market Share by Region (2027-2032) Table 18. Pharma Regulatory Intelligence Service Industry Trends Table 19. Pharma Regulatory Intelligence Service Industry Drivers Table 20. Pharma Regulatory Intelligence Service Industry Opportunities and Challenges Table 21. Pharma Regulatory Intelligence Service Market Restraints Table 22. Global Top Pharma Regulatory Intelligence Service Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Pharma Regulatory Intelligence Service Revenue Market Share by Players (2021-2026) Table 24. Global Pharma Regulatory Intelligence Service Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Pharma Regulatory Intelligence Service, Headquarters and Area Served Table 26. Global Pharma Regulatory Intelligence Service Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Pharma Regulatory Intelligence Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Pharma Regulatory Intelligence Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Pharma Regulatory Intelligence Service Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Pharma Regulatory Intelligence Service Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Pharma Regulatory Intelligence Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Pharma Regulatory Intelligence Service Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Pharma Regulatory Intelligence Service Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Pharma Regulatory Intelligence Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Pharma Regulatory Intelligence Service Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Pharma Regulatory Intelligence Service Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Pharma Regulatory Intelligence Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Pharma Regulatory Intelligence Service Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Pharma Regulatory Intelligence Service Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Pharma Regulatory Intelligence Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Pharma Regulatory Intelligence Service Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Pharma Regulatory Intelligence Service Market Size by Country (2027-2032) & (US$ Million) Table 45. ProPharma Company Information Table 46. ProPharma Business Overview Table 47. ProPharma Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 48. ProPharma Pharma Regulatory Intelligence Service Product Portfolio Table 49. ProPharma Recent Developments Table 50. IQVIA Company Information Table 51. IQVIA Business Overview Table 52. IQVIA Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 53. IQVIA Pharma Regulatory Intelligence Service Product Portfolio Table 54. IQVIA Recent Developments Table 55. Clarivate Company Information Table 56. Clarivate Business Overview Table 57. Clarivate Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 58. Clarivate Pharma Regulatory Intelligence Service Product Portfolio Table 59. Clarivate Recent Developments Table 60. InfoDesk Company Information Table 61. InfoDesk Business Overview Table 62. InfoDesk Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 63. InfoDesk Pharma Regulatory Intelligence Service Product Portfolio Table 64. InfoDesk Recent Developments Table 65. Vigilare Company Information Table 66. Vigilare Business Overview Table 67. Vigilare Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 68. Vigilare Pharma Regulatory Intelligence Service Product Portfolio Table 69. Vigilare Recent Developments Table 70. DDReg Pharma Company Information Table 71. DDReg Pharma Business Overview Table 72. DDReg Pharma Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 73. DDReg Pharma Pharma Regulatory Intelligence Service Product Portfolio Table 74. DDReg Pharma Recent Developments Table 75. Redica Systems Company Information Table 76. Redica Systems Business Overview Table 77. Redica Systems Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 78. Redica Systems Pharma Regulatory Intelligence Service Product Portfolio Table 79. Redica Systems Recent Developments Table 80. ArisGlobal Company Information Table 81. ArisGlobal Business Overview Table 82. ArisGlobal Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 83. ArisGlobal Pharma Regulatory Intelligence Service Product Portfolio Table 84. ArisGlobal Recent Developments Table 85. Freyr Company Information Table 86. Freyr Business Overview Table 87. Freyr Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 88. Freyr Pharma Regulatory Intelligence Service Product Portfolio Table 89. Freyr Recent Developments Table 90. PPD Company Information Table 91. PPD Business Overview Table 92. PPD Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 93. PPD Pharma Regulatory Intelligence Service Product Portfolio Table 94. PPD Recent Developments Table 95. Ergomed Company Information Table 96. Ergomed Business Overview Table 97. Ergomed Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 98. Ergomed Pharma Regulatory Intelligence Service Product Portfolio Table 99. Ergomed Recent Developments Table 100. SCR Consulting Company Information Table 101. SCR Consulting Business Overview Table 102. SCR Consulting Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 103. SCR Consulting Pharma Regulatory Intelligence Service Product Portfolio Table 104. SCR Consulting Recent Developments Table 105. CUBE Company Information Table 106. CUBE Business Overview Table 107. CUBE Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 108. CUBE Pharma Regulatory Intelligence Service Product Portfolio Table 109. CUBE Recent Developments Table 110. Vistaar Company Information Table 111. Vistaar Business Overview Table 112. Vistaar Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 113. Vistaar Pharma Regulatory Intelligence Service Product Portfolio Table 114. Vistaar Recent Developments Table 115. ProductLife Group Company Information Table 116. ProductLife Group Business Overview Table 117. ProductLife Group Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 118. ProductLife Group Pharma Regulatory Intelligence Service Product Portfolio Table 119. ProductLife Group Recent Developments Table 120. Deontea Company Information Table 121. Deontea Business Overview Table 122. Deontea Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 123. Deontea Pharma Regulatory Intelligence Service Product Portfolio Table 124. Deontea Recent Developments Table 125. PrimeVigilance Company Information Table 126. PrimeVigilance Business Overview Table 127. PrimeVigilance Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 128. PrimeVigilance Pharma Regulatory Intelligence Service Product Portfolio Table 129. PrimeVigilance Recent Developments Table 130. Deloitte Company Information Table 131. Deloitte Business Overview Table 132. Deloitte Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 133. Deloitte Pharma Regulatory Intelligence Service Product Portfolio Table 134. Deloitte Recent Developments Table 135. Cullen International Company Information Table 136. Cullen International Business Overview Table 137. Cullen International Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 138. Cullen International Pharma Regulatory Intelligence Service Product Portfolio Table 139. Cullen International Recent Developments Table 140. Arriello Company Information Table 141. Arriello Business Overview Table 142. Arriello Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 143. Arriello Pharma Regulatory Intelligence Service Product Portfolio Table 144. Arriello Recent Developments Table 145. Veristat Company Information Table 146. Veristat Business Overview Table 147. Veristat Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 148. Veristat Pharma Regulatory Intelligence Service Product Portfolio Table 149. Veristat Recent Developments Table 150. Celegence Company Information Table 151. Celegence Business Overview Table 152. Celegence Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 153. Celegence Pharma Regulatory Intelligence Service Product Portfolio Table 154. Celegence Recent Developments Table 155. Zenovel Company Information Table 156. Zenovel Business Overview Table 157. Zenovel Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 158. Zenovel Pharma Regulatory Intelligence Service Product Portfolio Table 159. Zenovel Recent Developments Table 160. STUP Company Information Table 161. STUP Business Overview Table 162. STUP Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 163. STUP Pharma Regulatory Intelligence Service Product Portfolio Table 164. STUP Recent Developments Table 165. iVigee Company Information Table 166. iVigee Business Overview Table 167. iVigee Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 168. iVigee Pharma Regulatory Intelligence Service Product Portfolio Table 169. iVigee Recent Developments Table 170. QbD Group Company Information Table 171. QbD Group Business Overview Table 172. QbD Group Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 173. QbD Group Pharma Regulatory Intelligence Service Product Portfolio Table 174. QbD Group Recent Developments Table 175. Biomapas Company Information Table 176. Biomapas Business Overview Table 177. Biomapas Revenue in Pharma Regulatory Intelligence Service Business (2021-2026) & (US$ Million) Table 178. Biomapas Pharma Regulatory Intelligence Service Product Portfolio Table 179. Biomapas Recent Developments Table 180. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pharma Regulatory Intelligence Service Product Image Figure 5. Global Pharma Regulatory Intelligence Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Pharma Regulatory Intelligence Service Market Share by Type: 2025 VS 2032 Figure 7. Database Driven Services Product Figure 8. Software Based Services Product Figure 9. Artificial Intelligence Services Product Figure 10. Global Pharma Regulatory Intelligence Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Pharma Regulatory Intelligence Service Market Share by Application: 2025 VS 2032 Figure 12. Pharmaceuticals Product Figure 13. Medical Devices Product Figure 14. Other Product Figure 15. Global Pharma Regulatory Intelligence Service Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 16. Global Pharma Regulatory Intelligence Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Pharma Regulatory Intelligence Service Market Share by Region: 2025 VS 2032 Figure 18. Global Pharma Regulatory Intelligence Service Market Share by Players in 2025 Figure 19. Global Pharma Regulatory Intelligence Service Manufacturers Established Date Figure 20. Global Top 5 and 10 Pharma Regulatory Intelligence Service Players Market Share by Revenue in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. North America Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Pharma Regulatory Intelligence Service Market Share by Country (2021-2032) Figure 24. United States Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Canada Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Mexico Pharma Regulatory Intelligence Service Market Share by Country (2021-2032) Figure 27. Europe Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Europe Pharma Regulatory Intelligence Service Market Share by Country (2021-2032) Figure 29. Germany Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. France Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. U.K. Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Italy Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Spain Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Russia Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Netherlands Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Nordic Countries Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Pharma Regulatory Intelligence Service Market Share by Country (2021-2032) Figure 39. China Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Japan Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. South Korea Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Pharma Regulatory Intelligence Service Market Share by Country (2021-2032) Figure 44. Australia Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. China Taiwan Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Southeast Asia Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Pharma Regulatory Intelligence Service Market Share by Country (2021-2032) Figure 49. Brazil Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Argentina Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Chile Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Colombia Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Peru Pharma Regulatory Intelligence Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. ProPharma Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 55. IQVIA Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 56. Clarivate Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 57. InfoDesk Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 58. Vigilare Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 59. DDReg Pharma Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 60. Redica Systems Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 61. ArisGlobal Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 62. Freyr Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 63. PPD Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 64. Ergomed Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 65. SCR Consulting Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 66. CUBE Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 67. Vistaar Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 68. ProductLife Group Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 69. Deontea Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 70. PrimeVigilance Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 71. Deloitte Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 72. Cullen International Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 73. Arriello Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 74. Veristat Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 75. Celegence Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 76. Zenovel Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 77. STUP Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 78. iVigee Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 79. QbD Group Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026) Figure 80. Biomapas Revenue Growth Rate in Pharma Regulatory Intelligence Service Business (2021-2026)

Scope & coverage.

Types
  • Database Driven Services
  • Software Based Services
  • Artificial Intelligence Services
Applications
  • Pharmaceuticals
  • Medical Devices
  • Other
Companies covered
  • ProPharma
  • IQVIA
  • Clarivate
  • InfoDesk
  • Vigilare
  • DDReg Pharma
  • Redica Systems
  • ArisGlobal
  • Freyr
  • PPD
  • Ergomed
  • SCR Consulting
  • CUBE
  • Vistaar
  • ProductLife Group
  • Deontea
  • PrimeVigilance
  • Deloitte
  • Cullen International
  • Arriello
  • Veristat
  • Celegence
  • Zenovel
  • STUP
  • iVigee
  • QbD Group
  • Biomapas

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Pharma Regulatory Intelligence Service by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Database Driven Services
  5. 2.2.3 Software Based Services
  6. 2.2.4 Artificial Intelligence Services
  7. 2.3 Pharma Regulatory Intelligence Service by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  9. 2.3.2 Pharmaceuticals
  10. 2.3.3 Medical Devices
  11. 2.3.4 Other
  12. 2.4 Assumptions and Limitations
3 Pharma Regulatory Intelligence Service Breakdown Data by Type
  1. 3.1 Global Pharma Regulatory Intelligence Service Historic Market Size by Type (2021-2026)
  2. 3.2 Global Pharma Regulatory Intelligence Service Forecasted Market Size by Type (2027-2032)
4 Pharma Regulatory Intelligence Service Breakdown Data by Application
  1. 4.1 Global Pharma Regulatory Intelligence Service Historic Market Size by Application (2021-2026)
  2. 4.2 Global Pharma Regulatory Intelligence Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Pharma Regulatory Intelligence Service Market Perspective (2021-2032)
  2. 5.2 Global Pharma Regulatory Intelligence Service Growth Trends by Region
  3. 5.2.1 Global Pharma Regulatory Intelligence Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Pharma Regulatory Intelligence Service Historic Market Size by Region (2021-2026)
  5. 5.2.3 Pharma Regulatory Intelligence Service Forecasted Market Size by Region (2027-2032)
  6. 5.3 Pharma Regulatory Intelligence Service Market Dynamics
  7. 5.3.1 Pharma Regulatory Intelligence Service Industry Trends
  8. 5.3.2 Pharma Regulatory Intelligence Service Market Drivers
  9. 5.3.3 Pharma Regulatory Intelligence Service Market Challenges
  10. 5.3.4 Pharma Regulatory Intelligence Service Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Pharma Regulatory Intelligence Service Players by Revenue
  2. 6.1.1 Global Top Pharma Regulatory Intelligence Service Players by Revenue (2021-2026)
  3. 6.1.2 Global Pharma Regulatory Intelligence Service Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Pharma Regulatory Intelligence Service Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Pharma Regulatory Intelligence Service Head Office and Area Served
  6. 6.4 Global Pharma Regulatory Intelligence Service Players, Product Type & Application
  7. 6.5 Global Pharma Regulatory Intelligence Service Manufacturers Established Date
  8. 6.6 Global Pharma Regulatory Intelligence Service Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Pharma Regulatory Intelligence Service Market Size (2021-2032)
  2. 7.2 North America Pharma Regulatory Intelligence Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Pharma Regulatory Intelligence Service Market Size by Country (2021-2026)
  4. 7.4 North America Pharma Regulatory Intelligence Service Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Pharma Regulatory Intelligence Service Market Size (2021-2032)
  2. 8.2 Europe Pharma Regulatory Intelligence Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Pharma Regulatory Intelligence Service Market Size by Country (2021-2026)
  4. 8.4 Europe Pharma Regulatory Intelligence Service Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharma Regulatory Intelligence Service Market Size (2021-2032)
  2. 9.2 Asia-Pacific Pharma Regulatory Intelligence Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Pharma Regulatory Intelligence Service Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Pharma Regulatory Intelligence Service Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Pharma Regulatory Intelligence Service Market Size (2021-2032)
  2. 10.2 South America Pharma Regulatory Intelligence Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Pharma Regulatory Intelligence Service Market Size by Country (2021-2026)
  4. 10.4 South America Pharma Regulatory Intelligence Service Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharma Regulatory Intelligence Service Market Size (2021-2032)
  2. 11.2 Middle East & Africa Pharma Regulatory Intelligence Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Pharma Regulatory Intelligence Service Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Pharma Regulatory Intelligence Service Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 ProPharma
  2. 12.1.1 ProPharma Company Information
  3. 12.1.2 ProPharma Business Overview
  4. 12.1.3 ProPharma Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  5. 12.1.4 ProPharma Pharma Regulatory Intelligence Service Product Portfolio
  6. 12.1.5 ProPharma Recent Developments
  7. 12.2 IQVIA
  8. 12.2.1 IQVIA Company Information
  9. 12.2.2 IQVIA Business Overview
  10. 12.2.3 IQVIA Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  11. 12.2.4 IQVIA Pharma Regulatory Intelligence Service Product Portfolio
  12. 12.2.5 IQVIA Recent Developments
  13. 12.3 Clarivate
  14. 12.3.1 Clarivate Company Information
  15. 12.3.2 Clarivate Business Overview
  16. 12.3.3 Clarivate Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  17. 12.3.4 Clarivate Pharma Regulatory Intelligence Service Product Portfolio
  18. 12.3.5 Clarivate Recent Developments
  19. 12.4 InfoDesk
  20. 12.4.1 InfoDesk Company Information
  21. 12.4.2 InfoDesk Business Overview
  22. 12.4.3 InfoDesk Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  23. 12.4.4 InfoDesk Pharma Regulatory Intelligence Service Product Portfolio
  24. 12.4.5 InfoDesk Recent Developments
  25. 12.5 Vigilare
  26. 12.5.1 Vigilare Company Information
  27. 12.5.2 Vigilare Business Overview
  28. 12.5.3 Vigilare Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  29. 12.5.4 Vigilare Pharma Regulatory Intelligence Service Product Portfolio
  30. 12.5.5 Vigilare Recent Developments
  31. 12.6 DDReg Pharma
  32. 12.6.1 DDReg Pharma Company Information
  33. 12.6.2 DDReg Pharma Business Overview
  34. 12.6.3 DDReg Pharma Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  35. 12.6.4 DDReg Pharma Pharma Regulatory Intelligence Service Product Portfolio
  36. 12.6.5 DDReg Pharma Recent Developments
  37. 12.7 Redica Systems
  38. 12.7.1 Redica Systems Company Information
  39. 12.7.2 Redica Systems Business Overview
  40. 12.7.3 Redica Systems Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  41. 12.7.4 Redica Systems Pharma Regulatory Intelligence Service Product Portfolio
  42. 12.7.5 Redica Systems Recent Developments
  43. 12.8 ArisGlobal
  44. 12.8.1 ArisGlobal Company Information
  45. 12.8.2 ArisGlobal Business Overview
  46. 12.8.3 ArisGlobal Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  47. 12.8.4 ArisGlobal Pharma Regulatory Intelligence Service Product Portfolio
  48. 12.8.5 ArisGlobal Recent Developments
  49. 12.9 Freyr
  50. 12.9.1 Freyr Company Information
  51. 12.9.2 Freyr Business Overview
  52. 12.9.3 Freyr Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  53. 12.9.4 Freyr Pharma Regulatory Intelligence Service Product Portfolio
  54. 12.9.5 Freyr Recent Developments
  55. 12.10 PPD
  56. 12.10.1 PPD Company Information
  57. 12.10.2 PPD Business Overview
  58. 12.10.3 PPD Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  59. 12.10.4 PPD Pharma Regulatory Intelligence Service Product Portfolio
  60. 12.10.5 PPD Recent Developments
  61. 12.11 Ergomed
  62. 12.11.1 Ergomed Company Information
  63. 12.11.2 Ergomed Business Overview
  64. 12.11.3 Ergomed Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  65. 12.11.4 Ergomed Pharma Regulatory Intelligence Service Product Portfolio
  66. 12.11.5 Ergomed Recent Developments
  67. 12.12 SCR Consulting
  68. 12.12.1 SCR Consulting Company Information
  69. 12.12.2 SCR Consulting Business Overview
  70. 12.12.3 SCR Consulting Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  71. 12.12.4 SCR Consulting Pharma Regulatory Intelligence Service Product Portfolio
  72. 12.12.5 SCR Consulting Recent Developments
  73. 12.13 CUBE
  74. 12.13.1 CUBE Company Information
  75. 12.13.2 CUBE Business Overview
  76. 12.13.3 CUBE Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  77. 12.13.4 CUBE Pharma Regulatory Intelligence Service Product Portfolio
  78. 12.13.5 CUBE Recent Developments
  79. 12.14 Vistaar
  80. 12.14.1 Vistaar Company Information
  81. 12.14.2 Vistaar Business Overview
  82. 12.14.3 Vistaar Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  83. 12.14.4 Vistaar Pharma Regulatory Intelligence Service Product Portfolio
  84. 12.14.5 Vistaar Recent Developments
  85. 12.15 ProductLife Group
  86. 12.15.1 ProductLife Group Company Information
  87. 12.15.2 ProductLife Group Business Overview
  88. 12.15.3 ProductLife Group Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  89. 12.15.4 ProductLife Group Pharma Regulatory Intelligence Service Product Portfolio
  90. 12.15.5 ProductLife Group Recent Developments
  91. 12.16 Deontea
  92. 12.16.1 Deontea Company Information
  93. 12.16.2 Deontea Business Overview
  94. 12.16.3 Deontea Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  95. 12.16.4 Deontea Pharma Regulatory Intelligence Service Product Portfolio
  96. 12.16.5 Deontea Recent Developments
  97. 12.17 PrimeVigilance
  98. 12.17.1 PrimeVigilance Company Information
  99. 12.17.2 PrimeVigilance Business Overview
  100. 12.17.3 PrimeVigilance Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  101. 12.17.4 PrimeVigilance Pharma Regulatory Intelligence Service Product Portfolio
  102. 12.17.5 PrimeVigilance Recent Developments
  103. 12.18 Deloitte
  104. 12.18.1 Deloitte Company Information
  105. 12.18.2 Deloitte Business Overview
  106. 12.18.3 Deloitte Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  107. 12.18.4 Deloitte Pharma Regulatory Intelligence Service Product Portfolio
  108. 12.18.5 Deloitte Recent Developments
  109. 12.19 Cullen International
  110. 12.19.1 Cullen International Company Information
  111. 12.19.2 Cullen International Business Overview
  112. 12.19.3 Cullen International Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  113. 12.19.4 Cullen International Pharma Regulatory Intelligence Service Product Portfolio
  114. 12.19.5 Cullen International Recent Developments
  115. 12.20 Arriello
  116. 12.20.1 Arriello Company Information
  117. 12.20.2 Arriello Business Overview
  118. 12.20.3 Arriello Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  119. 12.20.4 Arriello Pharma Regulatory Intelligence Service Product Portfolio
  120. 12.20.5 Arriello Recent Developments
  121. 12.21 Veristat
  122. 12.21.1 Veristat Company Information
  123. 12.21.2 Veristat Business Overview
  124. 12.21.3 Veristat Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  125. 12.21.4 Veristat Pharma Regulatory Intelligence Service Product Portfolio
  126. 12.21.5 Veristat Recent Developments
  127. 12.22 Celegence
  128. 12.22.1 Celegence Company Information
  129. 12.22.2 Celegence Business Overview
  130. 12.22.3 Celegence Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  131. 12.22.4 Celegence Pharma Regulatory Intelligence Service Product Portfolio
  132. 12.22.5 Celegence Recent Developments
  133. 12.23 Zenovel
  134. 12.23.1 Zenovel Company Information
  135. 12.23.2 Zenovel Business Overview
  136. 12.23.3 Zenovel Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  137. 12.23.4 Zenovel Pharma Regulatory Intelligence Service Product Portfolio
  138. 12.23.5 Zenovel Recent Developments
  139. 12.24 STUP
  140. 12.24.1 STUP Company Information
  141. 12.24.2 STUP Business Overview
  142. 12.24.3 STUP Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  143. 12.24.4 STUP Pharma Regulatory Intelligence Service Product Portfolio
  144. 12.24.5 STUP Recent Developments
  145. 12.25 iVigee
  146. 12.25.1 iVigee Company Information
  147. 12.25.2 iVigee Business Overview
  148. 12.25.3 iVigee Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  149. 12.25.4 iVigee Pharma Regulatory Intelligence Service Product Portfolio
  150. 12.25.5 iVigee Recent Developments
  151. 12.26 QbD Group
  152. 12.26.1 QbD Group Company Information
  153. 12.26.2 QbD Group Business Overview
  154. 12.26.3 QbD Group Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  155. 12.26.4 QbD Group Pharma Regulatory Intelligence Service Product Portfolio
  156. 12.26.5 QbD Group Recent Developments
  157. 12.27 Biomapas
  158. 12.27.1 Biomapas Company Information
  159. 12.27.2 Biomapas Business Overview
  160. 12.27.3 Biomapas Revenue in Pharma Regulatory Intelligence Service Business (2021-2026)
  161. 12.27.4 Biomapas Pharma Regulatory Intelligence Service Product Portfolio
  162. 12.27.5 Biomapas Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst